Javier de la Rubia Comos-rekin lankidetzan egindako argitalpenak (1)

2023

  1. Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

    Cancers, Vol. 15, Núm. 11